<DOC>
	<DOC>NCT00153569</DOC>
	<brief_summary>This trial assesses the clinical efficacy of a multiepitope peptide vaccine with GM-CSF and KLH as immunological adjuvants in stage IV melanoma patients</brief_summary>
	<brief_title>Multiepitope Peptide Vaccination in Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Metastatic melanoma HLAA1, A2, A24, B44</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>